






































































Owt O3460 O11778 O14484 A549
(ATCC)
Awt A3460 A11778
2 D2S1338 24,25 24,25 24,25 24,25 24,25 24,25 24,25
2 TPOX 11 11 11 11 11 8,11 8,11 8,11 8,11




3 D3S1358 15 15 15 15 16 16 16,17
4 FGA 24 24 24 24 23 23 23
5 D5S818 13 13 13 13 13 11 11,12 11,12 11
5 CSF1PO 12 12 12 12 12 10,12 10,12 10,12 10,12
7 D7S820 11,12 11,12 11,12 11,12 11,12 8,11 8,11 8,11 8,11
8 D8S1179 11,14 11,14 11,14 11,14 13,14 13,14 13,14
11 TH01 6 6 6 6 6 8,9.3 8,9.3 8,9.3 8,9.3
12 vWA 18 18 18 18 18 14 14 14 14
13 D13S317 12 12 12 12 12 11 11 11 11
16 D16S539 10,13 10,13 10,13 10,13 10,13 11,12 11,12 11,12 11,12
18 D18S51 17 17 17 17 14,17 14,17 14,17
19 D19S433 13 13 13 13 13 13 13
21 D21S11 31.2,32.2 31.2,32.2 31.2,32.2 31.2,32.2 29 29 29,30
X AMEL X X X X X X,Y X,Y X,Y X,Y
Chr,	chromosome.	ATCC,	American	type	culture	collection.	Italic	numbers	indicate	differences	between	A549	cybrids.
B.	mtDNA	sequence
Cybrid Owt O3460 O11778 O14484 Awt A3460 A11778
GenBank JN635299 MH080305 MH080306 MH080307 KT002149 MH080308 MH080309
Haplogroup J1c8a J1c2e2 J1c1b J2a2c U5a1a2b T2b T2a1b1a1b
Pathologic 3460 11778 14484 3460 11778






























































To	 check	 the	phenotypic	 effect	 of	 these	LHON	mutations	 in	 cybrids,	we	 analyzed	 endogenous	 oxygen	 consumption,	which	provides	 clues	 on	 cell	 respiration	 (Hofhaus	et	 al.,	 1996),	 and	 active	 caspase-3	 levels,	 a	marker	 of
















Cybrid Rotenone Capsaicin Rolliniastatin-1
Osteosarcoma	143B
Owt y	=	-	11.0	x	+	92.8 y	=	-	2.0	x	+	115.0 y	=	-	0.12	x	+	114.0
R2 = 0.9215 R2 = 0.9964 R2 = 0.9582
O3460 y	=	-	10.8	x	+	101.7 y	=	-	2.0	x	+	91.9 y	=	-	0.15	x	+	109.3
R2 = 0.9982 R2 = 0.9535 R2 = 0.9582
O11778 y	=	-	11.9	x	+	89.1 y	=	-	1.6	x	+	103.7 y	=	-	0.08	x	+	109.1
R2 = 0.8867 R2 = 0.9983 R2 = 0.9802
O14484 y	=	-	11.2	x	+	92.4 y	=	-	1.9	x	+	105.8 y	=	-	0.09	x	+	107.8
R2 = 0.9404 R2 = 0.9990 R2 = 0.9823
Adenocarcinoma	A549
Awt y	=	-	11.2	x	+	100.2 y	=	-	1.9	x	+	114.1 y	=	-	0.07	x	+	105.6
R2 = 0.9674 R2 = 0.9742 R2 = 0.9876
A3460 y	=	-	13.0	x	+	108.2 y	=	-	2.2	x	+	85.8 y	=	-	0.11	x	+	101.7
R2 = 0.9870 R2 = 0.9282 R2 = 0.9990
A11778 y	=	-	13.3	x	+	95.4 y	=	-	1.5	x	+	101.7 y	=	-	0.11	x	+	113.9
R2 = 0.8861 R2 = 0.9803 R2 = 0.9819
All	correlations	were	statistically	significant	(P < 0.0001).














In	adenocarcinoma	A549	cybrids,	capsaicin	5 μM	decreases	oxygen	consumption	 in	A3460	and	A11778	cybrids	but	10 μM	 is	 required	 to	diminish	oxygen	consumption	 in	Awt	cybrids	 (Fig.	4B).	There	are	also	 significant	negative	 correlations




Tropical	 and	 subtropical	 annonaceous	 plants	 produce	 acetogenins.	 The	 quantities	 of	 acetogenins	 in	 annonaceous	 fruits	 are	 such	 that	 a	 cumulative	 dose	 sufficient	 to	 cause	 neurodegeneration	 in	 rats	 can	 be	 attained	 in	 humans	 by	 regular
consumption	within	a	year	(Hollerhage	et	al.,	2009).	In	Guadeloupe	(French	West	Indies)	there	is	an	unusually	high	incidence	of	atypical	parkinsonism,	which	has	been	linked	to	regular	consumption	of	these	plants,	in	particular	soursop	(Lannuzel	et	al.,


















levels	 in	 other	 cell	 lines,	 such	 as	 human	 cervical	 cancer	HeLa,	 osteosarcoma	U2OS	 and	MG63,	 and	 epidermoid	 carcinoma	 KBv200 cell	 lines,	 respectively	 (Agarwal	 et	 al.,	 2016;	Liang	 et	 al.,	 2009;	Ying	 et	 al.,	 2013).	 Both	 rotenone

















































We	have	previously	suggested	that	mtDNA	genetic	background	 in	 the	cytochrome	b	gene	might	affect	 the	 interaction	with	pesticides	or	pharmaceutical	drugs	 (Gomez-Duran	et	al.,	2011).	Moreover,	we	 found	 that	mtDNA
genetic	variation	modifies	the	off-target	effects	of	ribosomal	antibiotics	used	to	fight	pathogenic	bacteria	(Pacheu-Grau	et	al.,	2013),	and	that	the	widely	distributed	pollutant	tributyltin	chloride,	an	ATP	synthase	inhibitor,	modified	the
phenotypic	 effects	 caused	 by	 a	 pathological	 mtDNA	mutation	 (Lopez-Gallardo	 et	 al.,	 2016).	 Thus,	 considering	 the	 interaction	 between	 mtDNA	 and	 environment	 factors	 is	 going	 to	 be	 important	 to	 explain	 the	 pathogenicity	 of
mitochondrial	disease	due	to	mtDNA	mutations.
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Fig.	7	Molecular	model	of	the	bovine	p.	MT-ND1	subunit,	ortholog	of	human	p.	MT-ND1	subunit.	The	third	matrix-side	loop,	which	binds	rolliniastatin-1	bis-tetrahydrofuran	motif,	is	shown	in	red	color.	The	alanine	at	position	52,	which	is	mutated	to	threonine
in	m.3460G > A,	is	represented	in	green	color.	(For	interpretation	of	the	references	to	color	in	this	figure	legend,	the	reader	is	referred	to	the	Web	version	of	this	article.)
alt-text:	Fig.	7
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